NRG and PALLAS appoint Bertholt Leeftink (CEO) and Gerrit Zalm The NRG Foundation (previously: Foundation ECN) and the Foundation Preparation Pallas-reactor (PALLAS) have made an important step forward. The executive board members and the supervisory board members of both organizations will sit on the boards of both companies, via a so-called “personele unie” (a situation…
Petten HFR Will Produce Medical Isotopes Only With LEU The High Flux Reactor in Petten, operated by NRG, from now on produces only medical isotopes with low-enriched uranium (LEU). Until recently, the productions for NRG’s Belgian partner IRE were still based on high-enriched uranium, because IRE could not fully process low-enriched uranium. But now IRE…
NRG PALLAS and Curium Sustain Continuity in the Global Supply of Mo-99 NRG PALLAS (ENS Corporate Member) and Curium have recently extended their collaboration for the production of molybdenum-99, which decays into technetium-99m, through a new multi-year agreement, essential to ensure the continuity of medical isotope supply. This agreement underlines the shared dedication of both partners…